The story driving equity markets (S&P500 -8.8% for example) through April was more of the same: higher inflation, higher commodity prices, higher interest rates and lower valuations ascribed to growth companies. Whilst we understand the optimal portfolio positioning for such an environment has been to own commodities, cyclicals and value stocks, we also understand that playing this game profitably requires an ability to dance close to the door as macro-economic variables can change quickly. If we were to bet the portfolio based on a guess of the future economic environment, we would do so with the knowledge that we are likely to be right as often as we are wrong. Instead, we focus on where we have an edge.

Our edge is in identifying durable businesses that can grow their cash flows through the full economic cycle. Over a long enough time-horizon, we are likely to experience the full spectrum of economic environments. Similarly, over a long enough time horizon, highly durable growth companies will be worth multiples of the low return, cyclically-driven companies we seek to avoid.

Unsurprisingly, attribution was characterised by some of our growth companies moving lower: Tyro, IDP Education, Block & Aristocrat. We did experience an offset from our short positions however, most of which contributed positively this month. The shorts are doing their job of cushioning the damage caused by the longs. This will help the fund recover from a higher base when, eventually, a recovery does dome. Special mentions for our short contributors go to the speculative, cash burning companies, many of which have no revenue. Covid winners that are now covid sinners such as e-commerce and healthcare companies also contributed to performance on the short side.

In terms of future opportunity, there are two key areas forefront of our minds.

The first is the businesses that exhibit all of the ingredients for superior long-term shareholder returns (i.e. high ROIC, durable business models with proven execution) are getting cheaper and therefore implying higher future returns. We feel the sting of having many of these already represented in the portfolio but nonetheless are enthusiastic to accumulate more shares in these companies at increasingly attractive prices.

The second area of opportunity are also companies that have seen recent share-price weakness but are distinct from the first group in that there is little to no fundamental value to support their valuations. These companies are often biotechs, aspiring resource producers or technology developers that lack a clear link between their cash burn and incremental revenue growth. Not only do these stocks do poorly when market sentiment becomes cautious, but they tend not to recover when sentiment returns due to a lack of execution and an investor base that has already moved on to the next shiny thing. Years of bullish share market conditions have presented a plethora of these opportunities and we continue to add them to our short portfolio.

The most obvious area of market speculation currently is in battery minerals. There is no shortage of these names on the ASX, however few are likely to have commercial operations. Unproven mining methods, chemical processes and or spicy jurisdictions that have never produced lithium before all loom as potential headwinds for these projects. Meanwhile, a lot of optimism has been built into projects that have a material chance of disappointing. Selectively and within risk tolerances, we have taken a short position in some of these names which worked in April.

As I have discussed in recent blogs, US ten-year treasury bonds have risen from approximately 0.5 per cent in mid-2020 and are now approaching 3.0 per cent. At the beginning of 2022, they were 1.5 per cent - and have effectively doubled in four months - as the concept of "transitory inflation" was reduced to rubble from the war in Ukraine pushing up commodity prices, continued supply bottlenecks and the general tightness of the labour markets as many economies exit COVID-19.

In many Western World economies, the rate of inflation is hitting between 30-to-40-year highs and examples include New Zealand at 6.9 per cent; the UK at 7.0 per cent; Germany at 7.3 per cent and the US at 8.5 per cent. Most Central Banks have moved very late in their tightening cycle and cash rates of around 1.0 to 1.5 per cent are still very low by historical standards. Australia's record low cash rate at 0.10 per cent compares, for example, with the "Emergency Low" cash rate of 3.0 per cent implemented on the back of the Global Financial Crisis over 13 years ago.

Much of the Western World adult population have enjoyed an enormous bull market for their prime asset - their house. But with house prices and household debt at record levels relative to household disposable income, indebted households will be sweating rising interest rates, and this could have a knock-on effect.

In the US, for example, 30-year fixed mortgages have hit 5.35 per cent, a 12-year high. Given they were under 3.0 per cent not so long ago, this has added around one-third to monthly mortgage payments on a standard 30-year repayment mortgage. And for those Americans buying today, post the 20 per cent year-on-year increase for the average house, this means they are now paying around 50 per cent more on the mortgage than they would have been a little over a year ago.

Buyers who fixed in a high proportion of their mortgage for some years will be less affected by rising interest rates. In the past I have pointed out that early in 2021, a four-year fixed loan in Australia was sub 2.0 per cent. Today, that rate is closer to 4.5 per cent. What this means is that today's housing buyers are taking out variable loans at closer to 2.3 per cent but are vulnerable to the RBA moving late with the interest rate tightening cycle.

No matter how you cut it, the psychological boost and wealth effect enjoyed from strongly rising house prices will likely be missing in the foreseeable future and this means indebted households are more vulnerable to Central Bank tightening late in this inflationary cycle.

Author:  David Buckland, Chief Executive Officer

Is the RBA risking a recession to solve inflation?

The RBA hikes rates by 25bps, with more set to come in 2022 as Australia's central bank attempts to keep a grip on inflation.

With oil and commodity prices set to continue to be at elevated levels due to Russia's war with Ukraine, could a series of rapid rate hikes rates push the Australian economy into recession??

Tune in to hear Darren and Chris discuss this in episode 27 of The Rate Debate.

The small and mid-cap universe offers the potential to invest in tomorrow's large companies today. In this article, we'll look at ways to navigate this huge global market while balancing the opportunities and risks.

Given a backdrop of conflict in Ukraine and a lingering pandemic, investors face a lot of uncertainty at the moment.

Due to concerns about inflation, interest rate rises and tightening monetary policy in early 2022, investors in small and mid-cap equities have been favouring "value" stocks with lower price-earnings (P/E) valuations over higher P/E "quality" companies recently.

We also saw small and mid-caps underperform large caps in 2021, based on the (not always accurate) perception that big equals safer.

There is now an opportunity to invest in quality small and mid-cap companies…at compelling valuations

All this means there is now an opportunity to invest in quality small and mid-cap companies with the potential to weather economic cycles.

These companies are available at compelling valuations. But in today's unpredictable environment, is it possible for investors to buy tomorrow's potential large caps without taking high risks?

Narrowing the search

The global small and mid-cap equity investable universe is vast. Two thirds of the world's listed corporates are small or mid-cap companies. That's 7850 stocks.1

Very few analysts cover the sector, which means experienced investors can exploit market inefficiencies.

With such a huge opportunity set, where do investors begin to look? At abrdn our starting point since the late 90s has been our stock screening matrix. Our information feeds measure the quality, growth, momentum and valuation factors that our continuous backtesting has found to be predictive of share price performance.

The above illustration shows the select companies we look for; those with strong quality, growth and momentum characteristics.

Our screening matrix highlights a shortlist of companies which look attractive from a quantitative perspective. Small and mid-cap specialists carry out rigorous fundamental research on these top-scoring companies, including meeting with senior management, financial analysis, an assessment of ESG risks and opportunities, as well as a peer review process.

The result is a 'best ideas list' which comprises of regional analysts' highest conviction names. Each list typically contains 15-20 stocks.

Our portfolios have high weights to these strongest conviction companies, while ensuring a sufficient level of diversification as well as clear, deliberate and persistent style tilts to quality, growth and momentum.

Factors in focus

We've talked about the factors that we believe are important when selecting companies with the potential to enlarge their market capitalisation over the long term. But what are the key indicators of these three characteristics?

Growth 

In our view, it's important to look for companies with profitable, sustainable, growth. Small and mid-cap businesses with supportive end markets, as well as the ability to gain market share and expand profit margins, have the greatest potential to become tomorrow's large caps.

Momentum

We also look for signs that companies are exhibiting momentum, such as seeing upward earnings revisions and a history of consistently beating earnings forecasts.

Growth and momentum characteristics have the potential to be sustained for many years, which partly explains why small caps have outperformed large caps over the long term.2

Quality

The graphic below shows what we believe are the key indicators of company quality:

Measures such as balance sheet strength, management pedigree and sustainable competitive advantage allow companies to successfully navigate changing economic cycles. Of course, investing in quality is also about avoiding loss-making, blue sky or highly leveraged businesses, as well as those with extremely cyclical earnings or a history of dividend cuts. Because of this, we believe, 'quality' companies have the potential to deliver higher returns over the long term with less volatility. This results in a more favourable risk-return profile. 

ESG - a key indicator of quality

One indicator shown above is ESG (environmental, social and governance). For us, ESG factors are financially material and can affect any company's performance both positively and negatively. A strong record on ESG issues is a key sign of company quality and can potentially help to reduce risk. Therefore, in our view, understanding ESG risks and opportunities should be an intrinsic part of any small and mid-cap research process, alongside other financial metrics.

We also think informed and constructive engagement with company leaders can help investment managers to encourage and share positive ESG practices - potentially protecting and enhancing the value of investments for years to come.

Well-resourced investment managers have the confidence to rely on their own ESG research, investing in companies which meet their own criteria, even when not covered by external ratings agencies. You can read more about The Importance of ESG in Small Cap Investing in our recent article.

Risk and opportunity

Looking forward, the outlook for higher interest rates, potentially sustained high inflation, and a lower growth environment suggest uncertain times are ahead.

Companies selected using a quality, growth and momentum process combined with ESG analysis are potentially well-placed to weather economic downturns. Far from being dependent on externally-driven cycles, these companies are likely to expand in a predictable, sustainable way.

They are also more likely to be market leaders able to pass on inflationary costs in the form of higher prices, as well as having strong margins and robust balance sheets. Furthermore, portfolios constructed in this way are more likely to be diversified across products, markets and geographies.

We also believe that in a changing world, smaller, nimble, well managed companies that can pivot their businesses more quickly than mega caps are well placed to take advantage of evolving opportunities.

Final thoughts

Many high quality small and mid-cap companies with the potential to expand and grow are currently available at attractive valuations. In today's uncertain world, we believe a robust, repeatable investment process focusing on quality, growth and momentum can help investors select the large cap leaders of the future with favourable risk-return profiles.

Author: Alexandra Popa, Macro ESG Research, Abrdn Research Institute

On Wednesday, April 27, Laureola Advisors shared an update on Q1 2022. 

Request for the recording now!

ABOUT LAUREOLA ADVISORS
Laureola Advisors was founded with the belief that investors deserve access to the unique benefits of Life Settlements, with the advantages of a specialist and focused asset manager. 

The best feature of the asset class is the genuine non-correlation with stocks, bonds, real estate, or hedge funds. Life Settlement investors will make money when others can't.

Like many asset classes, Life Settlements provides experienced and competent boutique managers like Laureola with significant advantages over larger institutional players.  In Life Settlements, the boutique manager can identify and close more opportunities in a cost effective manner, can move quickly when necessary, and can instantly adapt when opportunities dry up in one segment but appear in another. Larger investors are restricted not only by their size and natural inertia, but by self-imposed rules and criteria, which are typically designed by committees.

The Laureola Advisors team has transacted over $1 billion (US dollars) in face value of life insurance policies.